Nicolas Guisot

Nicolas Guisot currently serves as Vice President, Head of Development Science and Vice President of Drug Discovery at Redx Pharma, where responsibilities include leading teams in the development of small molecule inhibitors for oncology and fibrosis. Guisot plays a critical role in project design, execution, and communication across multidisciplinary teams, and has successfully led the discovery of Jaypirca™ (pirtobrutinib). Previous experience includes roles at Eli Lilly and Université du Maine, with a strong focus on synthesis and medicinal chemistry. Guisot completed a Ph.D. in Organic Chemistry at The University of Salford and holds a Master's degree in Chemistry of Biomolecules from Université de Montpellier II.